313 related articles for article (PubMed ID: 23962263)
1. Understanding efficacy end-points in studies of field-directed therapy for actinic keratosis.
Wolf JE; Rigel DS
Int J Dermatol; 2013 Sep; 52(9):1063-70. PubMed ID: 23962263
[TBL] [Abstract][Full Text] [Related]
2. Dual mechanism of action of ingenol mebutate gel for topical treatment of actinic keratoses: rapid lesion necrosis followed by lesion-specific immune response.
Rosen RH; Gupta AK; Tyring SK
J Am Acad Dermatol; 2012 Mar; 66(3):486-93. PubMed ID: 22055282
[TBL] [Abstract][Full Text] [Related]
3. Ingenol mebutate gel for actinic keratosis.
Lebwohl M; Swanson N; Anderson LL; Melgaard A; Xu Z; Berman B
N Engl J Med; 2012 Mar; 366(11):1010-9. PubMed ID: 22417254
[TBL] [Abstract][Full Text] [Related]
4. Randomized, double-blind, double-dummy, vehicle-controlled study of ingenol mebutate gel 0.025% and 0.05% for actinic keratosis.
Anderson L; Schmieder GJ; Werschler WP; Tschen EH; Ling MR; Stough DB; Katsamas J
J Am Acad Dermatol; 2009 Jun; 60(6):934-43. PubMed ID: 19467365
[TBL] [Abstract][Full Text] [Related]
5. Comparison of topical 5-fluorouracil formulations in actinic keratosis treatment.
Kaur RR; Alikhan A; Maibach HI
J Dermatolog Treat; 2010 Sep; 21(5):267-71. PubMed ID: 19878034
[TBL] [Abstract][Full Text] [Related]
6. Diclofenac sodium 3% gel for the management of actinic keratosis: 10+ years of cumulative evidence of efficacy and safety.
Martin GM; Stockfleth E
J Drugs Dermatol; 2012 May; 11(5):600-8. PubMed ID: 22527428
[TBL] [Abstract][Full Text] [Related]
7. Safety and tolerability of ingenol mebutate in the treatment of actinic keratosis.
Berman B
Expert Opin Drug Saf; 2015; 14(12):1969-78. PubMed ID: 26524598
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety assessment of 0.5% and 1% colchicine cream in the treatment of actinic keratoses.
Akar A; Bülent Taştan H; Erbil H; Arca E; Kurumlu Z; Gür AR
J Dermatolog Treat; 2001 Dec; 12(4):199-203. PubMed ID: 12241628
[TBL] [Abstract][Full Text] [Related]
9. Current issues in the management of actinic keratosis.
Ceilley RI; Jorizzo JL
J Am Acad Dermatol; 2013 Jan; 68(1 Suppl 1):S28-38. PubMed ID: 23228304
[TBL] [Abstract][Full Text] [Related]
10. The paradigm shift in treating actinic keratosis: a comprehensive strategy.
Stockfleth E
J Drugs Dermatol; 2012 Dec; 11(12):1462-7. PubMed ID: 23377517
[TBL] [Abstract][Full Text] [Related]
11. Therapies for actinic keratosis with a focus on cosmetic outcomes.
Lanoue J; Do T; Goldenberg G
Cutis; 2015 Sep; 96(3):165-72,93. PubMed ID: 26562273
[TBL] [Abstract][Full Text] [Related]
12. Topical treatment of actinic keratosis with 3.0% diclofenac in 2.5% hyaluronan gel: review of the literature about the cumulative evidence of its efficacy and safety.
Javor S; Cozzani E; Parodi A
G Ital Dermatol Venereol; 2016 Jun; 151(3):275-80. PubMed ID: 26512929
[TBL] [Abstract][Full Text] [Related]
13. Diclofenac Sodium 3% in Hyaluronic Acid 2.5% Gel Significantly Diminishes the Actinic Keratosis Area and Severity Index.
Schmitz L; Gupta G; Segert MH; Kost R; Sternberg J; Gambichler T; Stockfleth E; Dirschka T
Skin Pharmacol Physiol; 2018; 31(4):206-211. PubMed ID: 29791916
[TBL] [Abstract][Full Text] [Related]
14. Ingenol mebutate: a new option for actinic keratosis treatment.
Gras J
Drugs Today (Barc); 2013 Jan; 49(1):15-22. PubMed ID: 23362492
[TBL] [Abstract][Full Text] [Related]
15. PICATO (ingenol mebutate 0.015% and 0.05% gels): a novel treatment for actinic keratosis.
Abramovits W; Oquendo M; Vincent KD; Gupta AK
Skinmed; 2013; 11(2):111-5. PubMed ID: 23745230
[No Abstract] [Full Text] [Related]
16. Combining field therapies for actinic keratoses: novel approaches that intensify photodynamic therapy.
Kaminska EC; Tsoukas MM
Skinmed; 2013; 11(1):54-8. PubMed ID: 23540080
[TBL] [Abstract][Full Text] [Related]
17. Topical therapies for skin cancer and actinic keratosis.
Haque T; Rahman KM; Thurston DE; Hadgraft J; Lane ME
Eur J Pharm Sci; 2015 Sep; 77():279-89. PubMed ID: 26091570
[TBL] [Abstract][Full Text] [Related]
18. Field Therapy for Actinic Keratosis: A Structured Review of the Literature on Efficacy, Cost, and Adherence.
Lampley N; Rigo R; Schlesinger T; Rossi AM
Dermatol Surg; 2023 Feb; 49(2):124-129. PubMed ID: 36728061
[TBL] [Abstract][Full Text] [Related]
19. Long-term follow-up study of ingenol mebutate gel for the treatment of actinic keratoses.
Lebwohl M; Shumack S; Stein Gold L; Melgaard A; Larsson T; Tyring SK
JAMA Dermatol; 2013 Jun; 149(6):666-70. PubMed ID: 23553119
[TBL] [Abstract][Full Text] [Related]
20. Can topical calcipotriol be a treatment alternative in actinic keratoses? A preliminary report.
Seckin D; Cerman AA; Yildiz A; Ergun T
J Drugs Dermatol; 2009 May; 8(5):451-4. PubMed ID: 19537367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
